CD244 Antibody and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 CD244 (2B4) Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global CD244 (2B4) Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CD244 (2B4) Antibody Overall Market Size
2.1 Global CD244 (2B4) Antibody Market Size: 2024 VS 2032
2.2 Global CD244 (2B4) Antibody Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CD244 (2B4) Antibody Players in Global Market
3.2 Top Global CD244 (2B4) Antibody Companies Ranked by Revenue
3.3 Global CD244 (2B4) Antibody Revenue by Companies
3.4 Top 3 and Top 5 CD244 (2B4) Antibody Companies in Global Market, by Revenue in 2024
3.5 Global Companies CD244 (2B4) Antibody Product Type
3.6 Tier 1, Tier 2, and Tier 3 CD244 (2B4) Antibody Players in Global Market
3.6.1 List of Global Tier 1 CD244 (2B4) Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 CD244 (2B4) Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global CD244 (2B4) Antibody Market Size Markets, 2024 & 2032
4.1.2 Monoclonal Antibody
4.1.3 Polyclonal Antibody
4.2 Segmentation by Type - Global CD244 (2B4) Antibody Revenue & Forecasts
4.2.1 Segmentation by Type - Global CD244 (2B4) Antibody Revenue, 2020-2025
4.2.2 Segmentation by Type - Global CD244 (2B4) Antibody Revenue, 2026-2032
4.2.3 Segmentation by Type - Global CD244 (2B4) Antibody Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global CD244 (2B4) Antibody Market Size, 2024 & 2032
5.1.2 ELISA
5.1.3 Western Blot
5.1.4 Immunofluorescence
5.1.5 Others
5.2 Segmentation by Application - Global CD244 (2B4) Antibody Revenue & Forecasts
5.2.1 Segmentation by Application - Global CD244 (2B4) Antibody Revenue, 2020-2025
5.2.2 Segmentation by Application - Global CD244 (2B4) Antibody Revenue, 2026-2032
5.2.3 Segmentation by Application - Global CD244 (2B4) Antibody Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global CD244 (2B4) Antibody Market Size, 2024 & 2032
6.2 By Region - Global CD244 (2B4) Antibody Revenue & Forecasts
6.2.1 By Region - Global CD244 (2B4) Antibody Revenue, 2020-2025
6.2.2 By Region - Global CD244 (2B4) Antibody Revenue, 2026-2032
6.2.3 By Region - Global CD244 (2B4) Antibody Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America CD244 (2B4) Antibody Revenue, 2020-2032
6.3.2 United States CD244 (2B4) Antibody Market Size, 2020-2032
6.3.3 Canada CD244 (2B4) Antibody Market Size, 2020-2032
6.3.4 Mexico CD244 (2B4) Antibody Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe CD244 (2B4) Antibody Revenue, 2020-2032
6.4.2 Germany CD244 (2B4) Antibody Market Size, 2020-2032
6.4.3 France CD244 (2B4) Antibody Market Size, 2020-2032
6.4.4 U.K. CD244 (2B4) Antibody Market Size, 2020-2032
6.4.5 Italy CD244 (2B4) Antibody Market Size, 2020-2032
6.4.6 Russia CD244 (2B4) Antibody Market Size, 2020-2032
6.4.7 Nordic Countries CD244 (2B4) Antibody Market Size, 2020-2032
6.4.8 Benelux CD244 (2B4) Antibody Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia CD244 (2B4) Antibody Revenue, 2020-2032
6.5.2 China CD244 (2B4) Antibody Market Size, 2020-2032
6.5.3 Japan CD244 (2B4) Antibody Market Size, 2020-2032
6.5.4 South Korea CD244 (2B4) Antibody Market Size, 2020-2032
6.5.5 Southeast Asia CD244 (2B4) Antibody Market Size, 2020-2032
6.5.6 India CD244 (2B4) Antibody Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America CD244 (2B4) Antibody Revenue, 2020-2032
6.6.2 Brazil CD244 (2B4) Antibody Market Size, 2020-2032
6.6.3 Argentina CD244 (2B4) Antibody Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CD244 (2B4) Antibody Revenue, 2020-2032
6.7.2 Turkey CD244 (2B4) Antibody Market Size, 2020-2032
6.7.3 Israel CD244 (2B4) Antibody Market Size, 2020-2032
6.7.4 Saudi Arabia CD244 (2B4) Antibody Market Size, 2020-2032
6.7.5 UAE CD244 (2B4) Antibody Market Size, 2020-2032
7 Companies Profiles
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Corporate Summary
7.1.2 Sino Biological, Inc. Business Overview
7.1.3 Sino Biological, Inc. CD244 (2B4) Antibody Major Product Offerings
7.1.4 Sino Biological, Inc. CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.1.5 Sino Biological, Inc. Key News & Latest Developments
7.2 LifeSpan BioSciences, Inc
7.2.1 LifeSpan BioSciences, Inc Corporate Summary
7.2.2 LifeSpan BioSciences, Inc Business Overview
7.2.3 LifeSpan BioSciences, Inc CD244 (2B4) Antibody Major Product Offerings
7.2.4 LifeSpan BioSciences, Inc CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.2.5 LifeSpan BioSciences, Inc Key News & Latest Developments
7.3 Thermo Fisher
7.3.1 Thermo Fisher Corporate Summary
7.3.2 Thermo Fisher Business Overview
7.3.3 Thermo Fisher CD244 (2B4) Antibody Major Product Offerings
7.3.4 Thermo Fisher CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.3.5 Thermo Fisher Key News & Latest Developments
7.4 BioLegend
7.4.1 BioLegend Corporate Summary
7.4.2 BioLegend Business Overview
7.4.3 BioLegend CD244 (2B4) Antibody Major Product Offerings
7.4.4 BioLegend CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.4.5 BioLegend Key News & Latest Developments
7.5 Abbexa
7.5.1 Abbexa Corporate Summary
7.5.2 Abbexa Business Overview
7.5.3 Abbexa CD244 (2B4) Antibody Major Product Offerings
7.5.4 Abbexa CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.5.5 Abbexa Key News & Latest Developments
7.6 Abcam
7.6.1 Abcam Corporate Summary
7.6.2 Abcam Business Overview
7.6.3 Abcam CD244 (2B4) Antibody Major Product Offerings
7.6.4 Abcam CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.6.5 Abcam Key News & Latest Developments
7.7 Cell Signaling Technology, Inc.
7.7.1 Cell Signaling Technology, Inc. Corporate Summary
7.7.2 Cell Signaling Technology, Inc. Business Overview
7.7.3 Cell Signaling Technology, Inc. CD244 (2B4) Antibody Major Product Offerings
7.7.4 Cell Signaling Technology, Inc. CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.7.5 Cell Signaling Technology, Inc. Key News & Latest Developments
7.8 Arigo Biolaboratories Corp.
7.8.1 Arigo Biolaboratories Corp. Corporate Summary
7.8.2 Arigo Biolaboratories Corp. Business Overview
7.8.3 Arigo Biolaboratories Corp. CD244 (2B4) Antibody Major Product Offerings
7.8.4 Arigo Biolaboratories Corp. CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.8.5 Arigo Biolaboratories Corp. Key News & Latest Developments
7.9 Boster Biological Technology
7.9.1 Boster Biological Technology Corporate Summary
7.9.2 Boster Biological Technology Business Overview
7.9.3 Boster Biological Technology CD244 (2B4) Antibody Major Product Offerings
7.9.4 Boster Biological Technology CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.9.5 Boster Biological Technology Key News & Latest Developments
7.10 GeneTex
7.10.1 GeneTex Corporate Summary
7.10.2 GeneTex Business Overview
7.10.3 GeneTex CD244 (2B4) Antibody Major Product Offerings
7.10.4 GeneTex CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.10.5 GeneTex Key News & Latest Developments
7.11 MyBiosource, Inc.
7.11.1 MyBiosource, Inc. Corporate Summary
7.11.2 MyBiosource, Inc. Business Overview
7.11.3 MyBiosource, Inc. CD244 (2B4) Antibody Major Product Offerings
7.11.4 MyBiosource, Inc. CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.11.5 MyBiosource, Inc. Key News & Latest Developments
7.12 CUSABIO
7.12.1 CUSABIO Corporate Summary
7.12.2 CUSABIO Business Overview
7.12.3 CUSABIO CD244 (2B4) Antibody Major Product Offerings
7.12.4 CUSABIO CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.12.5 CUSABIO Key News & Latest Developments
7.13 Creative Diagnostics
7.13.1 Creative Diagnostics Corporate Summary
7.13.2 Creative Diagnostics Business Overview
7.13.3 Creative Diagnostics CD244 (2B4) Antibody Major Product Offerings
7.13.4 Creative Diagnostics CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.13.5 Creative Diagnostics Key News & Latest Developments
7.14 Bio-Techne
7.14.1 Bio-Techne Corporate Summary
7.14.2 Bio-Techne Business Overview
7.14.3 Bio-Techne CD244 (2B4) Antibody Major Product Offerings
7.14.4 Bio-Techne CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.14.5 Bio-Techne Key News & Latest Developments
7.15 AMSBIO
7.15.1 AMSBIO Corporate Summary
7.15.2 AMSBIO Business Overview
7.15.3 AMSBIO CD244 (2B4) Antibody Major Product Offerings
7.15.4 AMSBIO CD244 (2B4) Antibody Revenue in Global Market (2020-2025)
7.15.5 AMSBIO Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. CD244 (2B4) Antibody Market Opportunities & Trends in Global Market
Table 2. CD244 (2B4) Antibody Market Drivers in Global Market
Table 3. CD244 (2B4) Antibody Market Restraints in Global Market
Table 4. Key Players of CD244 (2B4) Antibody in Global Market
Table 5. Top CD244 (2B4) Antibody Players in Global Market, Ranking by Revenue (2024)
Table 6. Global CD244 (2B4) Antibody Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global CD244 (2B4) Antibody Revenue Share by Companies, 2020-2025
Table 8. Global Companies CD244 (2B4) Antibody Product Type
Table 9. List of Global Tier 1 CD244 (2B4) Antibody Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD244 (2B4) Antibody Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global CD244 (2B4) Antibody Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global CD244 (2B4) Antibody Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America CD244 (2B4) Antibody Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe CD244 (2B4) Antibody Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia CD244 (2B4) Antibody Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America CD244 (2B4) Antibody Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa CD244 (2B4) Antibody Revenue, (US$, Mn), 2026-2032
Table 30. Sino Biological, Inc. Corporate Summary
Table 31. Sino Biological, Inc. CD244 (2B4) Antibody Product Offerings
Table 32. Sino Biological, Inc. CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 33. Sino Biological, Inc. Key News & Latest Developments
Table 34. LifeSpan BioSciences, Inc Corporate Summary
Table 35. LifeSpan BioSciences, Inc CD244 (2B4) Antibody Product Offerings
Table 36. LifeSpan BioSciences, Inc CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 37. LifeSpan BioSciences, Inc Key News & Latest Developments
Table 38. Thermo Fisher Corporate Summary
Table 39. Thermo Fisher CD244 (2B4) Antibody Product Offerings
Table 40. Thermo Fisher CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 41. Thermo Fisher Key News & Latest Developments
Table 42. BioLegend Corporate Summary
Table 43. BioLegend CD244 (2B4) Antibody Product Offerings
Table 44. BioLegend CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 45. BioLegend Key News & Latest Developments
Table 46. Abbexa Corporate Summary
Table 47. Abbexa CD244 (2B4) Antibody Product Offerings
Table 48. Abbexa CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 49. Abbexa Key News & Latest Developments
Table 50. Abcam Corporate Summary
Table 51. Abcam CD244 (2B4) Antibody Product Offerings
Table 52. Abcam CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 53. Abcam Key News & Latest Developments
Table 54. Cell Signaling Technology, Inc. Corporate Summary
Table 55. Cell Signaling Technology, Inc. CD244 (2B4) Antibody Product Offerings
Table 56. Cell Signaling Technology, Inc. CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 57. Cell Signaling Technology, Inc. Key News & Latest Developments
Table 58. Arigo Biolaboratories Corp. Corporate Summary
Table 59. Arigo Biolaboratories Corp. CD244 (2B4) Antibody Product Offerings
Table 60. Arigo Biolaboratories Corp. CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 61. Arigo Biolaboratories Corp. Key News & Latest Developments
Table 62. Boster Biological Technology Corporate Summary
Table 63. Boster Biological Technology CD244 (2B4) Antibody Product Offerings
Table 64. Boster Biological Technology CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 65. Boster Biological Technology Key News & Latest Developments
Table 66. GeneTex Corporate Summary
Table 67. GeneTex CD244 (2B4) Antibody Product Offerings
Table 68. GeneTex CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 69. GeneTex Key News & Latest Developments
Table 70. MyBiosource, Inc. Corporate Summary
Table 71. MyBiosource, Inc. CD244 (2B4) Antibody Product Offerings
Table 72. MyBiosource, Inc. CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 73. MyBiosource, Inc. Key News & Latest Developments
Table 74. CUSABIO Corporate Summary
Table 75. CUSABIO CD244 (2B4) Antibody Product Offerings
Table 76. CUSABIO CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 77. CUSABIO Key News & Latest Developments
Table 78. Creative Diagnostics Corporate Summary
Table 79. Creative Diagnostics CD244 (2B4) Antibody Product Offerings
Table 80. Creative Diagnostics CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 81. Creative Diagnostics Key News & Latest Developments
Table 82. Bio-Techne Corporate Summary
Table 83. Bio-Techne CD244 (2B4) Antibody Product Offerings
Table 84. Bio-Techne CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 85. Bio-Techne Key News & Latest Developments
Table 86. AMSBIO Corporate Summary
Table 87. AMSBIO CD244 (2B4) Antibody Product Offerings
Table 88. AMSBIO CD244 (2B4) Antibody Revenue (US$, Mn) & (2020-2025)
Table 89. AMSBIO Key News & Latest Developments
List of Figures
Figure 1. CD244 (2B4) Antibody Product Picture
Figure 2. CD244 (2B4) Antibody Segment by Type in 2024
Figure 3. CD244 (2B4) Antibody Segment by Application in 2024
Figure 4. Global CD244 (2B4) Antibody Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global CD244 (2B4) Antibody Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global CD244 (2B4) Antibody Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by CD244 (2B4) Antibody Revenue in 2024
Figure 9. Segmentation by Type � Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global CD244 (2B4) Antibody Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 13. By Region - Global CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 14. By Country - North America CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 15. United States CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 16. Canada CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 19. Germany CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 20. France CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 22. Italy CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 23. Russia CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 27. China CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 28. Japan CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 31. India CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 33. Brazil CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa CD244 (2B4) Antibody Revenue Market Share, 2020-2032
Figure 36. Turkey CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 37. Israel CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 39. UAE CD244 (2B4) Antibody Revenue, (US$, Mn), 2020-2032
Figure 40. Sino Biological, Inc. CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. LifeSpan BioSciences, Inc CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Thermo Fisher CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. BioLegend CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Abbexa CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Abcam CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Cell Signaling Technology, Inc. CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Arigo Biolaboratories Corp. CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Boster Biological Technology CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. GeneTex CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. MyBiosource, Inc. CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. CUSABIO CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Creative Diagnostics CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Bio-Techne CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. AMSBIO CD244 (2B4) Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
